<DOC>
	<DOCNO>NCT02836652</DOCNO>
	<brief_summary>This study prospective , multi-center , randomize , double-blind placebo-controlled study subject receive HM II LVAD per current FDA approve indication use .</brief_summary>
	<brief_title>Prevention Non-Surgical Bleeding Management HeartMate II Patients Without Antiplatelet Therapy</brief_title>
	<detailed_description>This post-market clinical study HM II patient management practice conduct United States . Subjects randomize 1:1 fashion follow research drug group : 1 . Treatment Arm : Warfarin ( INR target : 2.0-2.5 , median : 2.25 ) + Placebo ( 1 pill/day ) 2 . Control Arm : Warfarin ( INR target : 2.0-2.5 , median : 2.25 ) + ASA Therapy ( 81mg/day ) The study investigate subject Treatment Arm experience reduce incidence non-surgical bleeding , without increase risk TE event .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>Inclusion Criteria Subject receive HM II per standard care ( SOC ) accordance FDA approve indication use Subject ≥ 60 year age Subject receive HM II first LVAD Subject legally authorize representative ( LAR ) sign informed consent form ( ICF ) . Exclusion Criteria Existence ongoing mechanical circulatory support ( MCS ) intraaortic balloon pump Participation clinical investigation ( ) involve MCS device , investigation ( ) likely confound study result affect study outcome Antiplatelet therapy mandate condition , particular : ) recent coronary artery stenting ( ≤ 6 month ) , b ) carotid artery disease , c ) condition investigator comfortable leave subject offASA start ASA post LVAD implantation . In situation investigator uncertain , Steering Committee provide recommendation investigator need . Subjects heart transplantation expect ≤ 6 month Subjects know ASA allergy</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>HeartMate II ( HMII )</keyword>
	<keyword>Left Ventricular Assist Device ( LVAD )</keyword>
</DOC>